Global Ventriculoperitoneal (VP) Shunt Market Insights, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 113

Report ID: 19189

An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed. This creates an alternative route for removal of CSF which is constantly produced within the brain and usually restores the physiological balance between CSF production, flow, and absorption when one or more of these functions has been impaired. Valves contained within the shunt pathway act like on-off switches, opening when the differential pressure (DP) – i.e., the pressure difference across the valve – exceeds the valve’s opening pressure. Valves are either set to a fixed pressure or they can be adjustable from outside the body. Accessory devices may be added to the shunt to modify valve function.
The global Ventriculoperitoneal (VP) Shunt market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Ventriculoperitoneal (VP) Shunt market based on company, product type, end user and key regions.

This report studies the global market size of Ventriculoperitoneal (VP) Shunt in key regions like North America, Europe, China and Japan, focuses on the consumption of Ventriculoperitoneal (VP) Shunt in these regions.
This research report categorizes the global Ventriculoperitoneal (VP) Shunt market by top players/brands, region, type and end user. This report also studies the global Ventriculoperitoneal (VP) Shunt market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sophysa
Aesculap
B. Braun Melsungen
Integra lifesciences
Medtronic
...

Ventriculoperitoneal (VP) Shunt market size by Type
Fixed Pressure Valves
Variable Pressure Valves

Ventriculoperitoneal (VP) Shunt market size by Applications
Hospitals
Clinics and Ambulatory Care centers
Laboratories
Others

Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Ventriculoperitoneal (VP) Shunt market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Ventriculoperitoneal (VP) Shunt market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ventriculoperitoneal (VP) Shunt companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ventriculoperitoneal (VP) Shunt submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Ventriculoperitoneal (VP) Shunt are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ventriculoperitoneal (VP) Shunt market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Ventriculoperitoneal (VP) Shunt Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Ventriculoperitoneal (VP) Shunt Market Size Growth Rate by Type
1.4.2 Fixed Pressure Valves
1.4.3 Variable Pressure Valves
1.5 Market by Application
1.5.1 Global Ventriculoperitoneal (VP) Shunt Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics and Ambulatory Care centers
1.5.4 Laboratories
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Ventriculoperitoneal (VP) Shunt Market Size
2.1.1 Global Ventriculoperitoneal (VP) Shunt Revenue 2014-2025
2.1.2 Global Ventriculoperitoneal (VP) Shunt Sales 2014-2025
2.2 Ventriculoperitoneal (VP) Shunt Growth Rate by Regions
2.2.1 Global Ventriculoperitoneal (VP) Shunt Sales by Regions
2.2.2 Global Ventriculoperitoneal (VP) Shunt Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Ventriculoperitoneal (VP) Shunt Sales by Manufacturers
3.1.1 Ventriculoperitoneal (VP) Shunt Sales by Manufacturers
3.1.2 Ventriculoperitoneal (VP) Shunt Sales Market Share by Manufacturers
3.2 Ventriculoperitoneal (VP) Shunt Revenue by Manufacturers
3.2.1 Ventriculoperitoneal (VP) Shunt Revenue by Manufacturers (2014-2019)
3.2.2 Ventriculoperitoneal (VP) Shunt Revenue Share by Manufacturers (2014-2019)
3.3 Ventriculoperitoneal (VP) Shunt Price by Manufacturers
3.4 Ventriculoperitoneal (VP) Shunt Manufacturing Base Distribution, Product Types
3.4.1 Ventriculoperitoneal (VP) Shunt Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ventriculoperitoneal (VP) Shunt Product Type
3.4.3 Date of International Manufacturers Enter into Ventriculoperitoneal (VP) Shunt Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Ventriculoperitoneal (VP) Shunt Sales by Type
4.2 Global Ventriculoperitoneal (VP) Shunt Revenue by Type
4.3 Ventriculoperitoneal (VP) Shunt Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Ventriculoperitoneal (VP) Shunt Breakdown Data by Application

6 North America
6.1 North America Ventriculoperitoneal (VP) Shunt by Country
6.1.1 North America Ventriculoperitoneal (VP) Shunt Sales by Country
6.1.2 North America Ventriculoperitoneal (VP) Shunt Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Ventriculoperitoneal (VP) Shunt by Type
6.3 North America Ventriculoperitoneal (VP) Shunt by Application

7 Europe
7.1 Europe Ventriculoperitoneal (VP) Shunt by Country
7.1.1 Europe Ventriculoperitoneal (VP) Shunt Sales by Country
7.1.2 Europe Ventriculoperitoneal (VP) Shunt Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ventriculoperitoneal (VP) Shunt by Type
7.3 Europe Ventriculoperitoneal (VP) Shunt by Application

8 Asia Pacific
8.1 Asia Pacific Ventriculoperitoneal (VP) Shunt by Region
8.1.1 Asia Pacific Ventriculoperitoneal (VP) Shunt Sales by Region
8.1.2 Asia Pacific Ventriculoperitoneal (VP) Shunt Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Ventriculoperitoneal (VP) Shunt by Type
8.3 Asia Pacific Ventriculoperitoneal (VP) Shunt by Application

9 Central & South America
9.1 Central & South America Ventriculoperitoneal (VP) Shunt by Country
9.1.1 Central & South America Ventriculoperitoneal (VP) Shunt Sales by Country
9.1.2 Central & South America Ventriculoperitoneal (VP) Shunt Revenue by Country
9.1.3 Brazil
9.2 Central & South America Ventriculoperitoneal (VP) Shunt by Type
9.3 Central & South America Ventriculoperitoneal (VP) Shunt by Application

10 Middle East and Africa
10.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt by Country
10.1.1 Middle East and Africa Ventriculoperitoneal (VP) Shunt Sales by Country
10.1.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Ventriculoperitoneal (VP) Shunt by Type
10.3 Middle East and Africa Ventriculoperitoneal (VP) Shunt by Application

11 Company Profiles
11.1 Sophysa
11.1.1 Sophysa Company Details
11.1.2 Company Business Overview
11.1.3 Sophysa Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sophysa Ventriculoperitoneal (VP) Shunt Products Offered
11.1.5 Sophysa Recent Development
11.2 Aesculap
11.2.1 Aesculap Company Details
11.2.2 Company Business Overview
11.2.3 Aesculap Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Aesculap Ventriculoperitoneal (VP) Shunt Products Offered
11.2.5 Aesculap Recent Development
11.3 B. Braun Melsungen
11.3.1 B. Braun Melsungen Company Details
11.3.2 Company Business Overview
11.3.3 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2014-2019)
11.3.4 B. Braun Melsungen Ventriculoperitoneal (VP) Shunt Products Offered
11.3.5 B. Braun Melsungen Recent Development
11.4 Integra lifesciences
11.4.1 Integra lifesciences Company Details
11.4.2 Company Business Overview
11.4.3 Integra lifesciences Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Integra lifesciences Ventriculoperitoneal (VP) Shunt Products Offered
11.4.5 Integra lifesciences Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Company Business Overview
11.5.3 Medtronic Ventriculoperitoneal (VP) Shunt Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Medtronic Ventriculoperitoneal (VP) Shunt Products Offered
11.5.5 Medtronic Recent Development

12 Future Forecast
12.1 Ventriculoperitoneal (VP) Shunt Market Forecast by Regions
12.1.1 Global Ventriculoperitoneal (VP) Shunt Sales Forecast by Regions 2019-2025
12.1.2 Global Ventriculoperitoneal (VP) Shunt Revenue Forecast by Regions 2019-2025
12.2 Ventriculoperitoneal (VP) Shunt Market Forecast by Type
12.2.1 Global Ventriculoperitoneal (VP) Shunt Sales Forecast by Type 2019-2025
12.2.2 Global Ventriculoperitoneal (VP) Shunt Revenue Forecast by Type 2019-2025
12.3 Ventriculoperitoneal (VP) Shunt Market Forecast by Application
12.4 North America Ventriculoperitoneal (VP) Shunt Forecast
12.5 Europe Ventriculoperitoneal (VP) Shunt Forecast
12.6 Asia Pacific Ventriculoperitoneal (VP) Shunt Forecast
12.7 Central & South America Ventriculoperitoneal (VP) Shunt Forecast
12.8 Middle East and Africa Ventriculoperitoneal (VP) Shunt Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ventriculoperitoneal (VP) Shunt Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer